RDIF proposes Pfizer conduct joint trials with Sputnik Light as booster shot

"Delta cases surge in US & Israel shows mRNA vaccines need a heterogeneous booster to strengthen & prolong immune response. #SputnikV pioneered mix&match approach, combo trials & showed 83.1% efficacy vs Delta. Today RDIF offers Pfizer to start trial with Sputnik Light as booster," it said in a Tweet.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3gdqWKP
via IFTTT